» Articles » PMID: 35664529

Retinol Depletion in COVID-19

Overview
Publisher Elsevier
Date 2022 Jun 6
PMID 35664529
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: COVID-19 has been a devastating pandemic. There are indications that vitamin A is depleted during infections. Vitamin A is important in development and immune homeostasis. It has been used successfully in measles, RSV and AIDS infections. In this study, we aimed to measure the serum retinol levels in severe COVID-19 patients to assess the importance of vitamin A in the COVID-19 pathogenesis.

Methods: The serum retinol level was measured in two groups of patients: the COVID-19 group, which consisted of 27 severe COVID-19 patients hospitalized in the intensive care unit with respiratory failure, and the control group, which consisted of 23 patients without COVID-19 symptoms.

Results: The mean serum retinol levels were 0.37 mg/L in the COVID-19 group and 0.52 mg/L in the control group. The difference between the serum retinol levels in the two groups was statistically significant. There was no significant difference in retinol levels between different ages and genders within the COVID-19 group. Comorbidity did not affect serum retinol levels.

Conclusion: The serum retinol level was significantly lower in patients with severe COVID-19, and this difference was independent of age or underlying comorbidity. Our data show that retinol and retinoic acid signaling might be important in immunopathogenesis of COVID-19.

Citing Articles

Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19.

Gonzalez-Acedo A, Manzano-Moreno F, Garcia-Recio E, Ruiz C, De Luna-Bertos E, Costela-Ruiz V Nutrients. 2024; 16(18).

PMID: 39339670 PMC: 11434975. DOI: 10.3390/nu16183070.


Gene expression profiles in COVID-19-associated tracheal stenosis indicate persistent anti-viral response and dysregulated retinol metabolism.

Martins R, Weber J, Poulikidis K, Al Shetawi A, Latif M, Razi S BMC Res Notes. 2024; 17(1):140.

PMID: 38755665 PMC: 11100031. DOI: 10.1186/s13104-024-06775-y.


Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective.

Alvarez-Nuncio M, Ziegler T Curr Opin Gastroenterol. 2024; 40(2):99-105.

PMID: 38193299 PMC: 10872245. DOI: 10.1097/MOG.0000000000001000.


Vitamin A Deficiency, COVID-19, and Rhino-Orbital Mucormycosis (Black Fungus): An Analytical Perspective.

Sarohan A, Edipsoy S, Ozkurt Z, Ozlu C, Demir A, Cen O Adv Exp Med Biol. 2023; 1436:153-166.

PMID: 37253944 DOI: 10.1007/5584_2023_774.


Using system biology and bioinformatics to identify the influences of COVID-19 co-infection with influenza virus on COPD.

Liang Z, Zheng X, Wang Y, Chu K, Gao Y Funct Integr Genomics. 2023; 23(2):175.

PMID: 37221323 PMC: 10205564. DOI: 10.1007/s10142-023-01091-3.


References
1.
Sarohan A, Kizil M, Inkaya A, Mahmud S, Akram M, Cen O . A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal. 2021; 87:110121. PMC: 8380544. DOI: 10.1016/j.cellsig.2021.110121. View

2.
Lee H, Ko G . Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome. Sci Rep. 2016; 6:25835. PMC: 4867650. DOI: 10.1038/srep25835. View

3.
Lee C, Hsieh C, Ko W . Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent. Antibiotics (Basel). 2021; 10(11). PMC: 8614993. DOI: 10.3390/antibiotics10111294. View

4.
Njar V, Gediya L, Purushottamachar P, Chopra P, Vasaitis T, Khandelwal A . Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem. 2006; 14(13):4323-40. DOI: 10.1016/j.bmc.2006.02.041. View

5.
Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y . Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020; 10(5):766-788. PMC: 7102550. DOI: 10.1016/j.apsb.2020.02.008. View